Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously ...

The U.S. Small Molecule Innovator API CDMO Market offers growth opportunities fueled by rising demand for HPAPIs across ...

With rising demand comes new challenges: capacity constraints, shifting regulatory expectations, and the unique requirements of emerging modalities, like cell and gene therapies, are reshaping the ...

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter“Fujirebio”) today announced that ...

Competitive Landscape Analysis The global nutraceutical CDMO market is marked by the presence of established and emerging market players such as Catalent Inc.; Lonza; NutraScience Labs; Robinson ...

The global biologics CDMO market is experiencing significant ... and support innovation across the global biopharmaceutical landscape. Zydus Lifesciences Ltd. with an overarching purpose of ...

Zydus Lifesciences Ltd announced its entry into the global biologics contract development and manufacturing organisation (CDMO) business through its plan to acquire two state-of-the-art biologics ...